ESPERION THERAPEUTICS INC (ESPR)
US29664W1053 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to ESPR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 7.56. This target is 287.82% above the current price.
ESPR was analyzed by 14 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ESPR.
In the previous month the buy percentage consensus was at a similar level.
ESPR was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Needham | Reiterate | Buy -> Buy |
| 2024-03-25 | Needham | Reiterate | Buy -> Buy |
| 2024-03-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-27 | Needham | Reiterate | Buy -> Buy |
| 2023-11-20 | JP Morgan | Reiterate | Neutral |
| 2023-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-07 | Needham | Maintains | Buy -> Buy |
| 2023-10-02 | Needham | Reiterate | Buy -> Buy |
| 2023-08-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-02 | Needham | Maintains | Buy -> Buy |
| 2023-06-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-15 | B of A Securities | Upgrade | Underperform -> Buy |
| 2023-06-01 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-09 | Needham | Maintains | Buy |
| 2023-04-18 | Needham | Reiterate | Buy |
| 2023-03-28 | Needham | Reiterate | Buy |
| 2023-03-20 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-03-16 | Needham | Maintains | Buy |
| 2023-03-16 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2023-03-16 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-07 | Credit Suisse | Upgrade | Underperform -> Neutral |
| 2023-03-06 | JMP Securities | Reiterate | Market Outperform |
| 2023-03-06 | Needham | Maintains | Buy |
| 2023-03-06 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-27 | JP Morgan | Maintains | Neutral |
| 2023-02-27 | B of A Securities | Reiterate | Neutral |
| 2023-02-22 | Needham | Reiterate | Buy |
| 2023-02-03 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2022-11-02 | Morgan Stanley | Maintains | Underweight |